122 related articles for article (PubMed ID: 38150771)
1. A facile boronophenylalanine modified polydopamine dual drug-loaded nanoparticles for enhanced anti-tumor immune response in hepatocellular carcinoma comprehensive treatment.
Yang F; Dai L; Shi K; Liu Q; Pan M; Mo D; Deng H; Yuan L; Lu Y; Pan L; Yang T; Qian Z
Biomaterials; 2024 Mar; 305():122435. PubMed ID: 38150771
[TBL] [Abstract][Full Text] [Related]
2. Magnetite Nanoparticles and Spheres for Chemo- and Photothermal Therapy of Hepatocellular Carcinoma in vitro.
Jędrzak A; Grześkowiak BF; Golba K; Coy E; Synoradzki K; Jurga S; Jesionowski T; Mrówczyński R
Int J Nanomedicine; 2020; 15():7923-7936. PubMed ID: 33116509
[TBL] [Abstract][Full Text] [Related]
3. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
[TBL] [Abstract][Full Text] [Related]
4. An inorganic-organic-polymeric nanovehicle for targeting delivery of doxorubicin: Rational assembly, pH-stimulus release, and dual hyperthermia/chemotherapy of hepatocellular carcinoma.
Yang J; Wang Z; Mo C; Luo H; Li S; Mo Q; Qin Y; Yang F; Li X
J Photochem Photobiol B; 2023 Apr; 241():112682. PubMed ID: 36871489
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral Administration of Thermosensitive Hydrogel Co-Loaded with Norcantharidin Nanoparticles and Doxorubicin for the Treatment of Hepatocellular Carcinoma.
Gao B; Luo J; Liu Y; Su S; Fu S; Yang X; Li B
Int J Nanomedicine; 2021; 16():4073-4085. PubMed ID: 34163160
[TBL] [Abstract][Full Text] [Related]
6. Photothermally triggered cytosolic drug delivery of glucose functionalized polydopamine nanoparticles in response to tumor microenvironment for the GLUT1-targeting chemo-phototherapy.
Li Y; Hong W; Zhang H; Zhang TT; Chen Z; Yuan S; Peng P; Xiao M; Xu L
J Control Release; 2020 Jan; 317():232-245. PubMed ID: 31783048
[TBL] [Abstract][Full Text] [Related]
7. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract][Full Text] [Related]
8. Combining photothermal therapy and immunotherapy against melanoma by polydopamine-coated Al
Chen W; Qin M; Chen X; Wang Q; Zhang Z; Sun X
Theranostics; 2018; 8(8):2229-2241. PubMed ID: 29721075
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer.
Zhu D; Tao W; Zhang H; Liu G; Wang T; Zhang L; Zeng X; Mei L
Acta Biomater; 2016 Jan; 30():144-154. PubMed ID: 26602819
[TBL] [Abstract][Full Text] [Related]
10. NIR-responsive polydopamine-based calcium carbonate hybrid nanoparticles delivering artesunate for cancer chemo-photothermal therapy.
Zhong W; Wong KH; Xu F; Zhao N; Chen M
Acta Biomater; 2022 Jun; 145():135-145. PubMed ID: 35381398
[TBL] [Abstract][Full Text] [Related]
11. A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence.
Zhou T; Liang X; Wang P; Hu Y; Qi Y; Jin Y; Du Y; Fang C; Tian J
ACS Nano; 2020 Oct; 14(10):12679-12696. PubMed ID: 32909732
[TBL] [Abstract][Full Text] [Related]
12. Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma.
Ji B; Cai H; Yang Y; Peng F; Song M; Sun K; Yan F; Liu Y
Acta Biomater; 2020 Jul; 111():363-372. PubMed ID: 32434082
[TBL] [Abstract][Full Text] [Related]
13. Doxorubicin-Loaded Walnut-Shaped Polydopamine Nanomotor for Photothermal-Chemotherapy of Cancer.
Liu Y; Zhang Y; Wang J; Yang H; Zhou J; Zhao W
Bioconjug Chem; 2022 Apr; 33(4):726-735. PubMed ID: 35312294
[TBL] [Abstract][Full Text] [Related]
14. Designing pH-triggered drug release iron oxide nanocomposites for MRI-guided photothermal-chemoembolization therapy of liver orthotopic cancer.
Liu F; Li X; Li Y; Qi Y; Yuan H; He J; Li W; Zhou M
Biomater Sci; 2019 Apr; 7(5):1842-1851. PubMed ID: 30942214
[TBL] [Abstract][Full Text] [Related]
15. Development of ligand modified erythrocyte coated polydopamine nanomedicine to codeliver chemotherapeutic agent and oxygen for chemo-photothermal synergistic cancer therapy.
Zhang L; Huang P; Huang S; Wang T; Chen S; Chen Z; Zhou Y; Qin L
Int J Pharm; 2022 Oct; 626():122156. PubMed ID: 36058410
[TBL] [Abstract][Full Text] [Related]
16. CaP coated mesoporous polydopamine nanoparticles with responsive membrane permeation ability for combined photothermal and siRNA therapy.
Wang Z; Wang L; Prabhakar N; Xing Y; Rosenholm JM; Zhang J; Cai K
Acta Biomater; 2019 Mar; 86():416-428. PubMed ID: 30611792
[TBL] [Abstract][Full Text] [Related]
17. Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma.
Lu YF; Zhou JP; Zhou QM; Yang XY; Wang XJ; Yu JN; Zhang JG; Du YZ; Yu RS
J Nanobiotechnology; 2022 Jul; 20(1):351. PubMed ID: 35907841
[TBL] [Abstract][Full Text] [Related]
18. Multifunctional PEG modified DOX loaded mesoporous silica nanoparticle@CuS nanohybrids as photo-thermal agent and thermal-triggered drug release vehicle for hepatocellular carcinoma treatment.
Wu L; Wu M; Zeng Y; Zhang D; Zheng A; Liu X; Liu J
Nanotechnology; 2015 Jan; 26(2):025102. PubMed ID: 25517859
[TBL] [Abstract][Full Text] [Related]
19. Polydopamine-modified ZIF-8 nanoparticles as a drug carrier for combined chemo-photothermal osteosarcoma therapy.
Yin X; Ran S; Cheng H; Zhang M; Sun W; Wan Y; Shao C; Zhu Z
Colloids Surf B Biointerfaces; 2022 Aug; 216():112507. PubMed ID: 35523102
[TBL] [Abstract][Full Text] [Related]
20. Local application of doxorubicin- loaded Iron oxid nanoparticles and the vascular disrupting agent via the hepatic artery: chemoembolization-photothermal ablation treatment of hepatocellular carcinoma in rats.
Yuan H; Li X; Tang J; Zhou M; Liu F
Cancer Imaging; 2019 Nov; 19(1):71. PubMed ID: 31685015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
